Home
|
Contact Us
|
Sitemap
Overview
Management Team
Board of Directors
Scientific Advisory Board
Careers
Current Openings
Benefits
About Pathogen Inactivation
Conventional Blood Testing
International Consensus Conference on Pathogen Inactivation
Glossary of Terms
How INTERCEPT Works
Product Pipeline
Commercializing The INTERCEPT System
The INTERCEPT Blood System
Case Study
Abstracts
Archived Abstracts
Publications
Archived Publications
Investor Overview
Corporate Governance
Analyst Coverage
Press Releases
Investor Events
Webcasts
Annual Reports
SEC Filings
Stock Information
Ownership Summary
Information Request
Investor Contacts
RSS Feeds
2008 Archived Events
Investors
Investor Overview
Corporate Governance
Analyst Coverage
Press Releases
Investor Events
Webcasts
Annual Reports
SEC Filings
Stock Information
Ownership Summary
Information Request
Investor Contacts
RSS Feeds
Investor Overview
Corporate Governance
Analyst Coverage
Press Releases
Investor Events
Webcasts
Annual Reports
SEC Filings
Stock Information
Ownership Summary
Information Request
Investor Contacts
RSS Feeds
Press Releases
Webcast - Live
Q3 2009 Cerus Earnings Conference Call
10/29/09 at 4:15 p.m. ET
Receive Email Alerts
Normal
Press Release RSS
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
Date
Subject
March 2, 2010
March 2, 2010
Cerus to Present at Cowen and Company Annual Health Care Conference
February 23, 2010
February 23, 2010
Cerus Announces Fourth Quarter and Year-End 2009 Results
February 17, 2010
February 17, 2010
Data Presented at International Haemovigilance Seminar Confirm Safety of Cerus' INTERCEPT Blood System for Platelets and Plasma
February 9, 2010
February 9, 2010
Cerus to Collaborate with French National Transfusion Service on INTERCEPT Red Blood Cell Development
February 8, 2010
February 8, 2010
Cerus Corporation Reports Positive Outcome of Phase 1 Clinical Trial of INTERCEPT Red Blood Cells
February 4, 2010
February 4, 2010
Cerus to Release Fourth Quarter and Year-End 2009 Results on February 23, 2010
February 2, 2010
February 2, 2010
Cerus to Present at 12th Annual BIO CEO & Investor Conference
January 14, 2010
January 14, 2010
Cerus Corporation Reports Positive Outcome in European Study of 7-Day INTERCEPT Platelets
© 2010 Cerus Corporation
Legal
|
Privacy
Powered By Q4 Web Systems
3.5.7.1024